Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04564703
Title Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Myeloma Network
Indications

multiple myeloma

Therapies

Iberdomide

Age Groups: senior | adult
Covered Countries ITA | FRA


No variant requirements are available.